CAS 1687736-54-4

SGC707

Description:

SGC707, identified by its CAS number 1687736-54-4, is a small molecule that functions as a selective inhibitor of certain protein kinases, particularly those involved in cancer signaling pathways. This compound is characterized by its ability to modulate cellular processes by interfering with kinase activity, which plays a crucial role in cell proliferation and survival. SGC707 is typically studied in the context of cancer research, where it may exhibit potential therapeutic effects by inhibiting tumor growth and promoting apoptosis in cancer cells. The compound's structure includes specific functional groups that contribute to its binding affinity and selectivity for target kinases. Additionally, SGC707's pharmacokinetic properties, such as solubility and stability, are essential for its efficacy in biological systems. Ongoing research aims to further elucidate its mechanism of action, optimize its chemical properties, and evaluate its potential in clinical applications. As with many investigational compounds, safety and toxicity profiles are critical considerations in the development of SGC707 for therapeutic use.

Formula: C₁₆H₁₈N₄O₂

Synonyms:

• SGC 707;SGC707
• CS-2192
• Urea, N-6-isoquinolinyl-N'-[2-oxo-2-(1-pyrrolidinyl)ethyl]-
• N-6-Isoquinolinyl-N'-[2-oxo-2-(1-pyrrolidinyl)ethyl]urea
• SGC707

N-6-Isoquinolinyl-N'-[2-oxo-2-(1-pyrrolidinyl)ethyl]urea

CAS: 1687736-54-4

Formula: C₁₆H₁₈N₄O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 298.3397

Ref: IN-DA001Y9W

SGC707

CAS: 1687736-54-4

SGC707

Purity: ≥98%

Molecular weight: 298.34g/mol

Ref: 54-BUP11109

SGC707

CAS: 1687736-54-4

SGC707 is a potent, selective, and cell-active allosteric inhibitor of PRMT3.

Formula: C₁₆H₁₈N₄O₂

Purity: 99.75% - 99.89%

Color and Shape: Solid

Molecular weight: 298.34

Ref: TM-T3084

Urea, N-6-isoquinolinyl-N’-[2-oxo-2-(1-pyrrolidinyl)ethyl]-

CAS: 1687736-54-4

Purity: 97%

Molecular weight: 298.3460083

Ref: 10-F865768

SGC707

CAS: 1687736-54-4

SGC707 is a novel inhibitor of ATP binding cassette transporter that has been shown to inhibit the transcriptional regulation of fatty acid metabolism in cancer cells. SGC707 has been shown to potently inhibit the transcriptional activation of genes involved in fatty acid synthesis by histone proteins, including acetyl-CoA carboxylase and fatty acid synthase. SGC707 inhibits the epigenetic modification of histones, which results in reduced levels of acetyl-CoA carboxylase and fatty acid synthase proteins. This inhibition leads to decreased fat synthesis and accumulation in cancer cells.

Formula: C₁₆H₁₈N₄O₂

Purity: Min. 95%

Molecular weight: 298.34 g/mol

Ref: 3D-MSC73654